You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Gastroenterology

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

Learn about key drivers of type 2 inflammation in EoE and how they mediate progressive esophageal remodeling and impact patient burden.

Download
EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

Learning objectives

  • Identify key type 2 inflammatory cells (beyond eosinophils) and cytokines (including IL-4 and IL-13) involved in EoE pathophysiology
  • Evaluate the impact of chronic, persistent type 2 inflammation on patient quality of life

Description

Learn about the key drivers of type 2 inflammation in EoE and how chronic, progressive inflammation can lead to esophageal remodeling and negatively impact patient burden.

Tags
disease progressionquality of lifecoexisting diseases
MAT-US-2101723 v5.0 P - Exp. Date 04/26/2025

Related resources

Eosinophilic Esophagitis (EoE) Interactive Patient Case
Gastroenterology
interactivity

Eosinophilic Esophagitis (EoE) Interactive Patient Case

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease
Gastroenterology
Infographic

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease

Importance of Assessing Key Disease Domains in EoE Infographic
Gastroenterology
Infographic

Importance of Assessing Key Disease Domains in EoE Infographic

Pediatric EoE Disease Burden Infographic
Gastroenterology
Infographic

Pediatric EoE Disease Burden Infographic

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
Gastroenterology
expert video

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE
Gastroenterology
expert video

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Food Bolus Impaction: An Opportunity to Diagnose EoE
Gastroenterology
expert video

Food Bolus Impaction: An Opportunity to Diagnose EoE

Gap in Care Leads to Progression of Fibrosis in EoE
Gastroenterology
expert video

Gap in Care Leads to Progression of Fibrosis in EoE

Impact of Delayed EoE Diagnosis on Disease Progression and QoL
Gastroenterology
expert video

Impact of Delayed EoE Diagnosis on Disease Progression and QoL

Importance of Assessing Multiple Disease Domains in EoE
Gastroenterology
expert video

Importance of Assessing Multiple Disease Domains in EoE

The Need for Maintenance Therapy in EoE
Gastroenterology
expert video

The Need for Maintenance Therapy in EoE

Assessing EoE: Assessing Symptoms in Patients With EoE
Gastroenterology
expert video

Assessing EoE: Assessing Symptoms in Patients With EoE

Assessing EoE: Assessing Histologic Features in EoE
Gastroenterology
expert video

Assessing EoE: Assessing Histologic Features in EoE

EoE Burden and Pathophysiology of Type 2 Inflammation
Gastroenterology
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE
Gastroenterology
expert video

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE

Importance of Monitoring and Maintenance in EoE
Gastroenterology
Infographic

Importance of Monitoring and Maintenance in EoE

Piecing Together the Puzzle in Patients With EoE
Gastroenterology
interactivity

Piecing Together the Puzzle in Patients With EoE

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases
Gastroenterology
expert video

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

2022: EoE Year in Review
Gastroenterology
expert video

2022: EoE Year in Review

Scientific Advances in EoE and Impact on Clinical Practice
Gastroenterology
expert video

Scientific Advances in EoE and Impact on Clinical Practice

Keeping an Eye on Pediatric EoE
Gastroenterology
expert video

Keeping an Eye on Pediatric EoE

2021: EoE Year in Review - Pathophysiology
Gastroenterology
expert video

2021: EoE Year in Review - Pathophysiology

Overview of EoE Pathophysiology and the Impact on Patient Burden
Gastroenterology
expert video

Overview of EoE Pathophysiology and the Impact on Patient Burden

Patient Case - The Value of a Complete Pathology Report in EoE
Gastroenterology
expert video

Patient Case - The Value of a Complete Pathology Report in EoE

Patient Case - The Value of an Interdisciplinary Team in EoE Patient Care
Gastroenterology
expert video

Patient Case - The Value of an Interdisciplinary Team in EoE Patient Care

Interdisciplinary Care for EoE: Experts Offer Food for Thought
Gastroenterology
expert video

Interdisciplinary Care for EoE: Experts Offer Food for Thought

Assessing EoE: Using Endoscopic Features to Assess Disease Status
Gastroenterology
expert video

Assessing EoE: Using Endoscopic Features to Assess Disease Status

Assessing EoE: Measuring Quality of Life in Patients With EoE
Gastroenterology
expert video

Assessing EoE: Measuring Quality of Life in Patients With EoE

More Than Eosinophils: A Closer Look at the Pathophysiology of EoE
Gastroenterology
expert video

More Than Eosinophils: A Closer Look at the Pathophysiology of EoE

Managing the Risk of Fibrostenosis in EoE
Gastroenterology
expert video

Managing the Risk of Fibrostenosis in EoE

In It Together: An Interdisciplinary Approach to EoE Care
Gastroenterology
expert video

In It Together: An Interdisciplinary Approach to EoE Care

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?
Gastroenterology
audio

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis
Gastroenterology
audio

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Adaptive Behaviors in EoE Infographic
Gastroenterology
Infographic

Adaptive Behaviors in EoE Infographic

2021: EoE Year in Review
Gastroenterology
expert video

2021: EoE Year in Review

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region